Transcribed ultraconserved region in human cancers

RNA Biology

Volumn 10, Issue 12, 2013, Pages 1771-1777

  Peng, Jiang Chen ^a   Shen, Jun ^a   Ran, Zhi Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Aberrant expression; Cancers; Long non coding RNAs; Mechanism of regulation; Transcribed ultraconserved regions

Indexed keywords

HISTONE H3; LONG UNTRANSLATED RNA; MICRORNA; TRANSCRIBED ULTRACONSERVED REGION; ULTRACONSERVED REGION; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

CANCER DIAGNOSIS; CANCER GENE THERAPY; CANCER GROWTH; CARCINOGENESIS; CARCINOMA CELL; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CPG ISLAND; DOWN REGULATION; EPIGENETIC REPRESSION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENOME ANALYSIS; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; NEUROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROSTATE CANCER; REGULATORY MECHANISM; REVIEW; TUMOR SUPPRESSOR GENE;

ABERRANT EXPRESSION; CANCERS; LONG NON-CODING RNAS; MECHANISM OF REGULATION; TRANSCRIBED ULTRACONSERVED REGIONS;

ANIMALS; BASE SEQUENCE; CHROMOSOME FRAGILE SITES; CONSERVED SEQUENCE; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; MICE; MICRORNAS; NEOPLASMS; RATS; RNA, LONG NONCODING;

EID: 84893126637     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.26995     Document Type: Review

References (33)

1. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al.;FANTOM Consortium; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group). The transcriptional landscape of the mammalian genome. Science 2005; 309:1559-63; PMID:16141072; http://dx.doi.org/10.1126/science.1112014
2. Dermitzakis ET, Reymond A, Antonarakis SE. Conserved non-genic sequences - an unexpected feature of mammalian genomes. Nat Rev Genet 2005; 6:151-7; PMID:15716910; http://dx.doi.org/10.1038/nrg1527
3. Costa FF. Non-coding RNAs: lost in translation? Gene 2007; 386:1-10; PMID:17113247; http://dx.doi.org/10.1016/j.gene.2006.09.028
4. Amaral PP, Dinger ME, Mercer TR, Mattick JS. The eukaryotic genome as an RNA machine. Science 2008; 319:1787-9; PMID:18369136; http://dx.doi.org/10.1126/ science.1155472
5. Collins LJ, Penny D. The RNA infrastructure: dark matter of the eukaryotic cell? Trends Genet 2009; 25:120-8; PMID:19171405; http://dx.doi.org/10.1016/j.tig.2008.12.003
6. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002
7. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics 2013; 193:651-69; PMID:23463798; http://dx.doi.org/10.1534/ genetics.112.146704
8. Ghosal S, Das S, Chakrabarti J. Long noncoding RNAs: new players in the molecular mechanism for maintenance and differentiation of pluripotent stem cells. Stem Cells Dev 2013; 22:2240-53; PMID:23528033; http://dx.doi.org/10. 1089/scd.2013.0014
9. Qiu MT, Hu JW, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol 2013; 34:613-20; PMID:23359273; http://dx.doi.org/10.1007/s13277-013-0658-6
10. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, Haussler D. Ultraconserved elements in the human genome. Science 2004; 304:1321-5; PMID:15131266; http://dx.doi.org/10.1126/ science.1098119
11. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007; 12:215-29; PMID:17785203; http://dx.doi.org/10.1016/j.ccr.2007.07.027
12. Mestdagh P, Fredlund E, Pattyn F, Rihani A, Van Maerken T, Vermeulen J, Kumps C, Menten B, De Preter K, Schramm A, et al. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. Oncogene 2010; 29:3583-92; PMID:20383195; http://dx.doi.org/10.1038/onc.2010.106
13. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12:861-74; PMID:22094949; http://dx.doi.org/10.1038/nrg3074
14. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 2010; 29:6390-401; PMID:20802525; http://dx.doi.org/10.1038/onc.2010.361
15. Lujambio A, Esteller M. How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle 2009; 8:377-82; PMID:19177007; http://dx.doi.org/10.4161/cc.8.3.7526
16. Scaruffi P, Stigliani S, Moretti S, Coco S, De Vecchi C, Valdora F, Garaventa A, Bonassi S, Tonini GP. Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer 2009; 9:441; PMID:20003513; http://dx.doi.org/10.1186/1471-2407-9-441
17. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92; PMID:17320506; http://dx.doi.org/10.1016/j.cell.2007.01.029
18. Lujambio A, Esteller M. CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 2007; 6:1455-9; PMID:17581274; http://dx.doi.org/10.4161/cc.6.12.4408
19. Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer 2013; 12:13; PMID:23409773; http://dx.doi.org/10.1186/1476-4598-12-13
20. Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ, Terracciano L, Croce CM, Patel T. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci U S A 2011; 108:786-91; PMID:21187392; http://dx.doi.org/10.1073/pnas.1011098108
21. Sana J, Hankeova S, Svoboda M, Kiss I, Vyzula R, Slaby O. Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer. Oncology 2012; 82:114-8; PMID:22328099; http://dx.doi.org/10. 1159/000336479
22. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-50; PMID:16199517; http://dx.doi.org/10.1073/pnas.0506580102
23. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353:1793-801; PMID:16251535; http://dx.doi.org/10.1056/NEJMoa050995
24. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9:189-98; PMID:16530703; http://dx.doi.org/10.1016/j.ccr.2006.01.025
25. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103:2257-61; PMID:16461460; http://dx.doi.org/10.1073/pnas.0510565103
26. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008; 22:1095-105; PMID:18323801; http://dx.doi.org/10.1038/leu.2008.30
27. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010; 28:341-7; PMID:20351690; http://dx.doi.org/10.1038/nbt.1618
28. Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452:896-9; PMID:18368051; http://dx.doi.org/10.1038/nature06783
29. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G 3rd, Kenny PJ, Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008; 14:723-30; PMID:18587408; http://dx.doi.org/10. 1038/nm1784
30. Costa FF. Non-coding RNAs and new opportunities for the private sector. Drug Discov Today 2009; 14:446-52; PMID:19429503; http://dx.doi.org/10.1016/j. drudis.2009.01.008
31. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12:247-56; PMID:20173740
32. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17:330-9; PMID:21386836; http://dx.doi.org/ 10.1038/nm.2305
33. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137:1005-17; PMID:19524505; http://dx.doi.org/10.1016/j.cell.2009.04.021